Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common stock and additional paid-in capital	Treasury stock	Accumulated other comprehensive loss	Retained earnings
Beginning Balance at Dec. 31, 2021	$ 15,849,248	$ 4,024,561	$ (824,190)	$ (40,495)	$ 12,689,372
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options		22,708
Stock-based compensation expense		269,601
Other comprehensive income (loss)				(103,981)
Net income	3,038,398				3,038,398
Ending Balance at Jun. 30, 2022	19,075,974	4,316,870	(824,190)	(144,476)	15,727,770
Beginning Balance at Mar. 31, 2022	17,544,039	4,155,580	(824,190)	(74,170)	14,286,819
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options		10,898
Stock-based compensation expense		150,392
Other comprehensive income (loss)				(70,306)
Net income	1,440,951				1,440,951
Ending Balance at Jun. 30, 2022	19,075,974	4,316,870	(824,190)	(144,476)	15,727,770
Beginning Balance at Dec. 31, 2022	20,777,401	4,637,601	(824,190)	(217,306)	17,181,296
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options		59,478
Stock-based compensation expense		177,129
Repurchases of common stock to be held as treasury stock	(1,045,000)		(1,052,563)
Other comprehensive income (loss)				78,040
Net income	2,792,730				2,792,730
Ending Balance at Jun. 30, 2023	22,832,215	4,874,208	(1,876,753)	(139,266)	19,974,026
Beginning Balance at Mar. 31, 2023	21,828,196	4,762,395	(1,228,920)	(191,695)	18,486,416
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options		33,783
Stock-based compensation expense		78,030
Repurchases of common stock to be held as treasury stock	(645,000)		(647,833)
Other comprehensive income (loss)				52,429
Net income	1,487,610				1,487,610
Ending Balance at Jun. 30, 2023	$ 22,832,215	$ 4,874,208	$ (1,876,753)	$ (139,266)	$ 19,974,026